Novartis wins temporary pause to Entresto generic launch in US
A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' ...
Morningstar12h
Obesity Drug Market: The Next Wave of GLP-1 Competition
These new challengers are anticipated to account for roughly $70 billion of the total GLP-1 market, which is expected to be worth $200 billion by 2031. Our report on the obesity drug market ...
gastroenterologyadvisor19h
First Generic Version of Motegrity Approved and Now Available
The first generic version of Motegrity has been approved by the Food and Drug Administration and is now available.
Sporting News15h
Premier League top goal scorers 2024/2025: EPL golden boot rankings as Isak streak closes on Haaland, Salah
The 2024/25 Premier League campaign is heating up and with that comes the opportunity for players to break records, score late winners or even bang in an overhead kick. Last season saw Erling ...
policymed.com22h
Second Federal Trade Commission Report on Pharmacy Benefit Managers (PBM’s) Focuses on Specialty Generics
The Federal Trade Commission (FTC) released its second interim staff report “Specialty Generic Drugs a Growing Profit Center ...